Nov 14 (Reuters)-
Delta-Fly Pharma, Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2024 Sep 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Operating loss 916 mln loss 593 mln loss 1.82
Recurring loss 915 mln loss 599 mln loss 1.83
Net loss 917 mln loss 600 mln loss 1.83
EPS loss 111.44 yen loss 91.92 yen loss 222.34 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Delta-Fly Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T